Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virology

Immunofluorescence Method for Detection of Ebola Virus Immunoglobulin G, Using HeLa Cells Which Express Recombinant Nucleoprotein

Masayuki Saijo, Masahiro Niikura, Shigeru Morikawa, Ichiro Kurane
Masayuki Saijo
Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musahimurayama, Tokyo 208-0011, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiro Niikura
Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musahimurayama, Tokyo 208-0011, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeru Morikawa
Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musahimurayama, Tokyo 208-0011, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ichiro Kurane
Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musahimurayama, Tokyo 208-0011, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.39.2.776-778.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

A novel recombinant baculovirus which expresses Ebola virus (EBO) nucleoprotein (NP) under the control of the cytomegalovirus immediate-early promoter was constructed. HeLa cells abortively infected with the baculovirus expressed EBO NP, and this was used as an immunofluorescent (IF) antigen to detect EBO immunoglobulin G (IgG) antibody. This IF method has high efficacy in detecting EBO IgG antibody in clinical specimens, indicating its usefulness in the diagnosis of EBO infections and seroepidemiological studies.

The Ebola virus (EBO) is responsible for severe forms of hemorrhagic fever. The first EBO outbreak was recognized in Zaire and Sudan in 1976 (2, 9, 18, 19). Several western African countries were later struck by EBO outbreaks caused by one of the three known human-pathogenic EBO subtypes (1, 3, 4, 10, 12, 14a). Another EBO (Reston subtype [EBO-R]) outbreak occurred among captured cynomolgus monkeys (Macaca fascicularis) in the Philippines (6, 14, 15). EBO-R was imported from the Philippines to the United States by EBO-R-infected monkeys in 1989, 1990, and 1996 and was also imported to Italy in 1992 (6, 15).

We developed an indirect immunofluorescence (IF) method for the detection of immunoglobulin G (IgG) antibody to EBO, using HeLa cells expressing recombinant EBO (rEBO) nucleoprotein (NP) by gene transfer with a baculovirus system.

The baculovirus AcCMV-EBO-NP was constructed as follows. PCR was performed to add a BamHI site at each extremity of the NP gene of EBO subtype Zaire (16) using the primers EBO(Z)NP/F (5′-CAAGGATCCGAGTATGGATTCTCG-3′; theBamHI restriction site is underlined) and EBO(Z)NP/R (5′-ATGGATCCATGCTCATTCACTGATG-3′). The amplified DNA was digested with BamHI, purified, and subcloned into the BamHI site of pAcYM1CMV (17), resulting in the production of the recombinant transfer plasmid pAcYM1CMV-EBO-NP, which contains the DNA of EBO NP under the control of the cytomegalovirus immediate-early (CMV-IE) promoter. It was identified as having the correct orientation of EBO NP DNA relative to the promoter by restriction mapping. The entire insert was sequenced and was confirmed to be identical to that of the original cDNA. Tn5 cells were transfected with mixtures of purified AcNPV DNA and the transfer plasmid (11, 13), resulting in the production of the novel recombinant baculovirus AcCMV-EBO-NP. This baculovirus was expected to express EBO NP under the control of the CMV-IE promoter in mammalian cells upon abortive infection with the virus (5, 17). Ac-ΔP, a baculovirus which lacks the polyhedrin gene, was used as a negative control virus. These recombinant baculoviruses were grown in Tn5 cells as reported previously (13).

HeLa cells were infected with AcCMV-EBO-NP at a multiplicity of infection of 20 PFU/cell. The cells were incubated for 48 h in Dulbecco's minimal essential medium supplemented with 10% heat-inactivated fetal bovine serum and antibiotics. Then, the cells were harvested by trypsinization at 48 h postinfection, washed with phosphate-buffered saline (PBS), spotted on 14-well HT-Coated slide glasses (AR Brown Co., Ltd., Tokyo, Japan), air dried, and fixed with acetone at room temperature for 5 min. The slides (rEBO NP slides) were stored at −70°C until use. Negative-antigen slides were prepared similarly using Ac-ΔP-infected HeLa cells. The spot slides were thawed and dried before use.

For the IF test, twofold serial dilutions (1:25 to 1:102,400) of test sera were placed on both rEBO NP slides and negative slides, and the slides were incubated under humidified conditions at 37°C for 1 h. After a washing with PBS, the antigens were reacted with fluorescein isothiocyanate (FITC)-conjugated goat anti-human IgG antibody (1:50; Kirkegaard & Perry, Gaithersburg, Md.) and with FITC-conjugated goat anti-rabbit IgG antibody (1:50; Kirkegaard & Perry), when human and monkey sera and rabbit serum were tested, respectively. After a washing with PBS, the slides were examined for the staining pattern under a fluorescent microscope (Zeiss, Oberkochen, Germany) with appropriate barrier and excitation filters for FITC visualization. Positive and negative controls were included with each assay. The titers of tested samples were recorded as the reciprocals of the highest dilutions producing positive results.

To confirm the expression of rEBO NP in HeLa cells, an rEBO NP slide was stained with anti-EBO NP rabbit serum, which was raised against purified His-tagged rEBO NP. The AcCMV-EBO-NP-infected HeLa cells showed a granular staining pattern (Fig.1a), while the Ac-ΔP-infected HeLa cells did not show any staining (data not shown).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

IF staining patterns of rEBO NP-expressing HeLa cells. (a) IF staining pattern of rEBO NP-expressing HeLa cells with the anti-EBO NP rabbit serum. (b) Positive IF staining of rEBO NP-expressing HeLa cells with serum collected from a patient with EBO infection in the convalescent phase. (c) Positive IF staining with serum collected from an EBO-R-infected monkey.

Sera collected from 14 patients with EBO subtype Zaire infections (4 in the 1976 outbreak, 1 in the 1977 outbreak, and 9 in the 1995 outbreak of EBO Zaire) in the convalescent phase and 48 sera from subjects in West African countries without a history of EBO infection were tested by the IF test. All 14 patients' sera showed positive staining with a granular pattern (Fig. 1b). The Ac-ΔP-infected HeLa cells (negative control) did not show any staining (data not shown). The IgG antibody titers determined by the IF system in these human sera ranged from 1:25 to 1:25,600 (Fig. 2). The negative slides were not stained by any of these patients' sera. Among the 48 sera from subjects without a history of EBO infections, one showed positive staining at a dilution of 1:100 (Fig. 2). We could not rule out the possibility that this serum had IgG antibodies specific to EBO. Even if the positive reaction by 1 of the 48 control sera was nonspecific, the IF system using rEBO NP-expressing HeLa cells has high efficacy in detecting EBO-specific IgG, with 100% sensitivity and 98% specificity. The number of serum samples used for the evaluation of this IF system was small; these results indicate the usefulness of this IF method for detection of EBO-specific IgG antibody.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Titers of IgG antibody to rEBO NP in sera collected from 14 EBO-infected patients at the convalescent phase and in 48 control sera. All the 14 EBO sera showed a positive reaction by the IF method. Of the 48 control sera, only 1 showed an EBO IgG-positive reaction by the IF method at a titer of 1:100; the other 47 were negative by the IF method.

We wondered whether this IF system could also detect the EBO-R-specific IgG antibody, though the rEBO NP was derived from EBO subtype Zaire. To address this, sera collected from two EBO-R-infected cynomolgus monkeys (M. fascicularis) in an outbreak in 1996 (14) were tested by the IF method for the presence of EBO IgG antibody. Both sera showed typical positive staining as shown in Fig. 1c at a dilution of 1:25, while they showed no background staining with the negative slides (data not shown). The results suggest that the IgG antibody to EBO-R can be detected by the IF method using rEBO NP derived from EBO subtype Zaire.

Hofmann et al. (5) and Shoji et al. (17) reported that the novel baculovirus vector with the CMV-IE promoter could efficiently deliver and express foreign genes in mammalian cells. We confirmed that rEBO NP was efficiently expressed by gene transfer with the recombinant baculovirus AcCMV-EBO-NP in several mammalian cell lines. Among them, rEBO NP-expressing HeLa cells exhibited a unique staining pattern with anti-EBO NP rabbit serum (Fig. 1a). No cytopathic effect was observed in AcCMV-EBO-NP-inoculated HeLa cells because the virus infected the mammalian cells abortively, while EBO-infected cells showed a strong cytopathic effect which sometimes causes nonspecific reactions in the IF test. Because of the unique nature of the baculovirus-HeLa cell system, this IF method is considered efficacious in detecting EBO IgG with high sensitivity and specificity.

In previous reports on the seroepidemiology of EBO, inactivated EBO-infected cells were used as antigens for indirect IF methods (7, 8). Our IF method may offer an attractive alternative to the use of live EBO-infected cells, which should be handled in a biosafety level 4 laboratory.

ACKNOWLEDGMENTS

We thank R. F. Meyer, C. J. Peters, and T. G. Ksiazek, Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Ga., for providing us with the cDNA clone of EBO and human sera used in this study. We also thank M. E. Miranda, Research Institute of Tropical Medicine, The Philippines, for providing us with sera from EBO-R-infected monkeys.

This study was supported by a grant from the Ministry of Health and Welfare, Japan.

FOOTNOTES

    • Received 21 August 2000.
    • Returned for modification 29 September 2000.
    • Accepted 15 November 2000.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Amblard J.,
    2. Obiang P.,
    3. Prehaud C.,
    4. Bouloy M.,
    5. Le Guenno B.
    Identification of the Ebola virus in Gabon in 1994.Lancet3491995181182
    OpenUrl
  2. 2.↵
    1. Bowen E. T.,
    2. Lloyd G.,
    3. Harris W. J.,
    4. Platt G. S.,
    5. Baskerville A.,
    6. Vella E. E.
    Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent.Lancet1211977571573
    OpenUrlCrossRef
  3. 3.↵
    1. Formenty P.,
    2. Hatz C.,
    3. Le Guenno B.,
    4. Stoll A.,
    5. Rogenmoser P.,
    6. Widmer A.
    Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation.J. Infect. Dis.179 (Suppl. 1)1999S48S53
    OpenUrl
  4. 4.↵
    1. Georges A. J.,
    2. Leroy M. E.,
    3. Renaut A. A.,
    4. Benissan C. T.,
    5. Nabias R. J.,
    6. Ngoc M. T.,
    7. Obiang P. I.,
    8. Lepage J. P. M.,
    9. Bertherat E. J.,
    10. Bénoni D. D.,
    11. Wickings E. J.,
    12. Amblard J. P.,
    13. Lansoud-Soukate J. M.,
    14. Milleliri J. M.,
    15. Baize S.,
    16. Georges-Courbot M.
    Ebola hemorrhagic fever outbreaks in Gabon, 1994–1997: epidemiologic and health control issues.J. Infect. Dis.179 (Suppl. 1)1999S65S75
    OpenUrl
  5. 5.↵
    1. Hofmann C.,
    2. Sandig V.,
    3. Jennings G.,
    4. Rudolph M.,
    5. Schlag P.,
    6. Strauss M.
    Efficient gene transfer into human hepatocytes by baculovirus vectors.Proc. Natl. Acad. Sci. USA9219951009910103
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Jahrling P. B.,
    2. Geisbert T. W.,
    3. Dalgard D. W.,
    4. Johnson E. D.,
    5. Ksiazek T. G.,
    6. Hall W. C.,
    7. Peters C. J.
    Preliminary report: isolation of Ebola virus from monkeys imported to USA.Lancet3351990502505
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Johnson B. K.,
    2. Gitau L. G.,
    3. Gichogo A.,
    4. Tukei P. M.,
    5. Else J. G.,
    6. Sulman M. A.,
    7. Kimani R.,
    8. Sayer P. D.
    Marburg, Ebola and Rift Valley fever virus antibodies in East African primates.Trans. R. Soc. Trop. Med. Hyg.761982307310
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Johnson B. K.,
    2. Ocheng D.,
    3. Gichogo A.,
    4. Okiro M.,
    5. Libondo D.,
    6. Tukei P. M.,
    7. Ho M.,
    8. Mugambi M.,
    9. Timms G. L.,
    10. French M.
    Antibodies against haemorrhagic fever viruses in Kenya populations.Trans. R. Soc. Trop. Med. Hyg.771983731733
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Johnson K. M.,
    2. Lange J. V.,
    3. Webb P. A.,
    4. Murphy F. A.
    Isolation and partial characterization of a new virus causing acute haemorrhagic fever in Zaire.Lanceti1977569571
    OpenUrl
  10. 10.↵
    1. Khan A. S.,
    2. Tshioko F. K.,
    3. Heymann D. H.,
    4. Guenno B. L.,
    5. Nabeth P.,
    6. Kerstiës B.,
    7. Fleerackers Y.,
    8. Kilmarx P. H.,
    9. Rodier G. R.,
    10. Nkuku O.,
    11. Rollin P. E.,
    12. Sanchez A.,
    13. Zaki S. F.,
    14. Swabepoel R.,
    15. Tomori O.,
    16. Nichol S. T.,
    17. Peters C. J.,
    18. Muyembe-Tamfum J. J.,
    19. Ksiazek T. G.
    The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995.J. Infect. Dis.179 (Suppl. 1)1999S76S91
    OpenUrl
  11. 11.↵
    1. Kitts A. K.,
    2. Ayres M. D.,
    3. Possee R. D.
    Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors.Nucleic Acids Res.18199056675672
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Le Guenno B.,
    2. Formenty P.,
    3. Wyers M.,
    4. Gounon P.,
    5. Walker F.,
    6. Boesch C.
    Isolation and partial characterization of a new strain of Ebola virus.Lancet345199512711274
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Matsuura Y.,
    2. Possee R. D.,
    3. Overton H. A.,
    4. Bishop D.
    Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.J. Gen. Virol.68198712331250
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Miranda M. E.,
    2. Ksiazek T. G.,
    3. Retuya T. J.,
    4. Khan A. S.,
    5. Sanchez A.,
    6. Fulhorst C. F.,
    7. Rollin P. E.,
    8. Colaor A. B.,
    9. Manalo D. L.,
    10. Roces M. C.,
    11. Dayrit M. M.,
    12. Peters C. J.
    Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996.J. Infect. Dis.199 (Suppl. 1)1999S115S119
    OpenUrl
  15. 14a.↵
    1. Muyembe-Tamfum J. J.,
    2. Kipsa M.
    Ebola haemorrhagic fever in Kikwit, Zaire. International Scientific and Technical Committee and World Health Organization Collaborating Centre for Haemorrhagic Fevers.Lancet34519951448
    OpenUrlCrossRefPubMedWeb of Science
  16. 15.↵
    1. Rollin P. E.,
    2. Williams R. J.,
    3. Bressler D. S.,
    4. Pearson S.,
    5. Cottingham M.,
    6. Pucak G.,
    7. Sanchez A.,
    8. Trappier S. G.,
    9. Peters R. L.,
    10. Greer P. W.,
    11. Zaki S.,
    12. Demarcus T.,
    13. Hendricks K.,
    14. Kelley M.,
    15. Simpson D.,
    16. Geisbert T. W.,
    17. Jahring P. B.,
    18. Peters C. J.,
    19. Ksiazek T. G.
    Ebola subtype (Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States.J. Infect. Dis.179 (Suppl. 1)1999S108S114
    OpenUrl
  17. 16.↵
    1. Sanchez A.,
    2. Kiley M. P.,
    3. Holloway B. P.,
    4. McCormick J. B.,
    5. Auperin D. D.
    The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression.Virology17019898191
    OpenUrlCrossRefPubMed
  18. 17.↵
    1. Shoji I.,
    2. Aizaki H.,
    3. Tani H.,
    4. Ishii K.,
    5. Chiba T.,
    6. Saito I.,
    7. Miyamura T.,
    8. Matsuura Y.
    Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors.J. Gen. Virol.78199726572664
    OpenUrlPubMedWeb of Science
  19. 18.↵
    World Health Organization Ebola virus haemorrhagic fever in Sudan, 1976. Report of a World Health Organization International Study Team.Bull. W. H. O.561978247270
    OpenUrlPubMedWeb of Science
  20. 19.↵
    World Health Organization Ebola virus haemorrhagic fever in Zaire, 1976. Report from an international commission.Bull. W. H. O.561978271293
    OpenUrlPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Immunofluorescence Method for Detection of Ebola Virus Immunoglobulin G, Using HeLa Cells Which Express Recombinant Nucleoprotein
Masayuki Saijo, Masahiro Niikura, Shigeru Morikawa, Ichiro Kurane
Journal of Clinical Microbiology Feb 2001, 39 (2) 776-778; DOI: 10.1128/JCM.39.2.776-778.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Immunofluorescence Method for Detection of Ebola Virus Immunoglobulin G, Using HeLa Cells Which Express Recombinant Nucleoprotein
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immunofluorescence Method for Detection of Ebola Virus Immunoglobulin G, Using HeLa Cells Which Express Recombinant Nucleoprotein
Masayuki Saijo, Masahiro Niikura, Shigeru Morikawa, Ichiro Kurane
Journal of Clinical Microbiology Feb 2001, 39 (2) 776-778; DOI: 10.1128/JCM.39.2.776-778.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Antibodies, Viral
Ebolavirus
Hemorrhagic Fever, Ebola
immunoglobulin G

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X